Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
July 18, 2024
Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Article links to www.oxionics.com
July 11, 2024
Oxford Ionics breaks global quantum performance records
July 5, 2024
Times Commentary: Science innovation must be at the heart of government action
Article links to www.beacontx.com
July 3, 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Article links to www.prnewswire.com
June 21, 2024
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
Article links to www.globenewswire.com
June 10, 2024
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Article links to www.businesswire.com
May 23, 2024
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
May 22, 2024
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
All News
08•10•24
Portfolio News
Fluorok
FluoRok secures £700k grant to develop the UK supply of a crucial component of Lithium-ion batteries
01•10•24
Portfolio News
Barinthus Biotherapeutics
Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer
01•10•24
Portfolio News
Oxford Nanoimaging
ONI and Massive Photonics Announce a Successful Collaboration Bringing DNA-PAINT Technology to the Nanoimager
30•09•24
Portfolio News
Genomics
Genomics plc Announces David Thornton as President
24•09•24
Portfolio News
Barinthus Biotherapeutics
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
24•09•24
Portfolio News
Fluorok
FluoRok raises £7.7m ($9.8m) to transform the safety and sustainability of fluorochemical production
10•09•24
Portfolio News
Oxford Ionics
Oxford Ionics sets new world record in qubit readout
02•09•24
Portfolio News
Theolytics
Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK
23•08•24
Portfolio News
PepGen
PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
21•08•24
Portfolio News
PepGen
PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
20•08•24
Portfolio News
MoA Technology
Moa Announces International Field Trial Success at the ACS Autumn Conference in Denver
19•08•24
Portfolio News
Oxford Ionics
Oxford Ionics kicks off international expansion with new US office
13•08•24
Portfolio News
SpyBiotech
SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer
08•08•24
Portfolio News
PepGen
PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
08•08•24
Portfolio News
Barinthus Biotherapeutics
Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
31•07•24
Portfolio News
PepGen
PepGen Announces Positive Data from Low-Dose Cohort of PGN-EDO51 in Ongoing CONNECT1-EDO51 Phase 2 Clinical Trial for Treatment of Duchenne Muscular Dystrophy
30•07•24
Portfolio News
Iota Sciences
iotaSciences raises equity financing round to drive further business expansion for its automated single-cell biology handling technologies
26•07•24
Portfolio News
Fractile
Fractile raises $15 million to develop new AI Chip
24•07•24
Portfolio News
Beacon Therapeutics
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
23•07•24
Portfolio News
SpyBiotech
SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLO1 Targeting Human Cytomegalovirus (HCMV)
23•07•24
Portfolio News
Neu.Health Digital
Pioneering Parkinson’s Care: The First NHS Outcomes using the Neu Health Platform
19•07•24
Portfolio News
Mixergy
Daikin partner with Mixergy to offer unparalleled benefits for social housing retrofit and new build
18•07•24
OSE News
Oxford Semantic Technologies
Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
16•07•24
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Mark Bodmer as Chief Executive Officer
11•07•24
Portfolio News
Oxford Ionics
Oxford Ionics breaks global quantum performance records
08•07•24
Portfolio News
MoA Technology
Moa harvests global deal for new herbicide
05•07•24
OSE News
Times Commentary: Science innovation must be at the heart of government action
03•07•24
Portfolio News
Beacon Therapeutics
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
03•07•24
Portfolio News
Natcap
Natcap Secures $10 Million to Bring Nature into Business Decision-Making
02•07•24
Portfolio News
Sitryx
Sitryx announces leadership transition
02•07•24
Portfolio News
Sitryx
Sitryx announces leadership transition
21•06•24
Portfolio News
PQShield
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
19•06•24
OSE News
Oxford Science Enterprises Appoints Professor Dame Fiona Murray and Professor Sir Peter Donnelly as Non-Executive Directors
12•06•24
Portfolio News
Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
12•06•24
Portfolio News
Beacon Therapeutics
Beacon Therapeutics Treats First Patient in VISTA Registrational Trial for AGTC-501
10•06•24
Portfolio News
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
28•05•24
Portfolio News
Orbit Discovery
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
23•05•24
Portfolio News
Grey Wolf Therapeutics
Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology
23•05•24
Portfolio News
SpyBiotech
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
22•05•24
OSE News
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
21•05•24
Portfolio News
Oxford Endovascular
Oxford Endovascular – raises £8m to tackle brain aneurysms
30•04•24
Portfolio News
Scenic Biotech enters into Research Collaboration with Bristol Myers Squibb
30•04•24
Portfolio News
Genomics
Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design
29•04•24
Portfolio News
Evox Therapeutics
Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
29•04•24
Portfolio News
Caristo Diagnostics
Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies
25•04•24
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
17•04•24
OSE News
Oxford Science Enterprises welcomes Kirsty Lloyd-Jukes as an Entrepreneur in Residence to accelerate company creation
17•04•24
Portfolio News
Theolytics
Theolytics successfully closes latest financing raising total of £19M ($24.5M) and welcomes Sound Bioventures as new investor
10•04•24
Portfolio News
Sitryx
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
09•04•24
Portfolio News
Beacon Therapeutics
Ascend acquires GMP manufacturing capacity in Alachua, Florida; Enters long-term partnership with Beacon Therapeutics for clinical and commercial AAV production
09•04•24
Portfolio News
Genomics
Genomics plc and MassMutual's program enables more policyowners to understand health risks through innovative genetic testing
08•04•24
Portfolio News
OMass Therapeutics
OMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmann
28•03•24
Portfolio News
Oxford Nanoimaging
Revolutionizing EV Research: Introducing ONI’s Next-Generation End-to-End Solution
21•03•24
Portfolio News
Theolytics
Mike Grey appointed Executive Chair of Theolytics’ Board of Directors
13•03•24
Portfolio News
PepGen
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
13•03•24
Portfolio News
PepGen
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
05•03•24
Portfolio News
Oxford Quantum Circuits
Pioneering Quantum Computing in the Energy Industry: Chevron Joins OQC's $100 Million Round
27•02•24
Portfolio News
Amber Therapeutics
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
20•02•24
Portfolio News
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
08•02•24
Portfolio News
Beacon Therapeutics
Beacon Therapeutics Announces Positive 12-Month Data from Trial of Patients with X-Linked Retinitis Pigmentosa
07•02•24
Portfolio News
PepGen
PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock
05•02•24
Portfolio News
Quantum Motion Technologies
Quantum Motion wins bid to deliver first silicon quantum computing prototype to NQCC
05•02•24
Portfolio News
Orca Computing
ORCA Computing to Deploy Quantum Photonics Testbed to UK National Quantum Computing Centre
05•02•24
Portfolio News
Oxford Ionics
Oxford Ionics wins contract to deliver a quantum computer to the NQCC
01•02•24
OSE News
OSE's 2023 Highlights
01•02•24
Portfolio News
Genomics
Genomics publishes results of NHS trial in European Journal of Preventative Cardiology
31•01•24
Portfolio News
OMass Therapeutics
CEO Ros Deegan appointed to UK Prime Minister's Business Council
30•01•24
Portfolio News
Orca Computing
ORCA Computing Leaps Forward in Quantum Computing Race with Acquisition
25•01•24
Portfolio News
MoA Technology
Moa Reveals Data on Next-Generation Herbicides with New Modes of Action and Progress Towards Field Trials
17•01•24
Portfolio News
PepGen
Mary Beth DeLena Joins PepGen as General Counsel and Secretary
16•01•24
Portfolio News
Caristo Diagnostics
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation
09•01•24
Portfolio News
Ultromics
Ultromics announces partnership to expedite development of Echo AI algorithm
08•01•24
Portfolio News
Fluorok
FluoRok awarded £750k grant by UKRI’s Faraday Battery Challenge
08•01•24
Portfolio News
Genomics
Genomics raises £35mn for advanced genetic testing
08•01•24
Portfolio News
PepGen
PepGen Announces First Patient Dosed in Phase 2 Clinical Trial for Duchenne Muscular Dystrophy Patients
18•12•23
Portfolio News
PepGen
PepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1 Clinical Trial of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
12•12•23
Portfolio News
DiffBlue
Diffblue Announces Citi as a Strategic Investor
09•12•23
Portfolio News
Scenic Biotech
Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882
07•12•23
Portfolio News
SpyBiotech
SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01
05•12•23
Portfolio News
Evolito
Evolito First in UK to Secure CAA Design Organisation Approval for Electric Propulsion Systems
28•11•23
Portfolio News
Theolytics
Theolytics presents data at ESMO on its lead program being developed for Ovarian Cancer
27•11•23
Portfolio News
Oxford Quantum Circuits
OQC launches OQC Toshiko, the world’s first enterprise ready quantum platform
21•11•23
OSE News
OSE Response to Treasury's Independent Review of University Spinouts
16•11•23
Portfolio News
BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
15•11•23
Portfolio News
PepGen
PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors
15•11•23
Portfolio News
OMass Therapeutics
OMass Therapeutics expands leadership team with the appointment of Melissa Faris as Chief Business Officer
14•11•23
Portfolio News
Oxford Nanoimaging
ONI Welcomes Dr. Alex Aravanis, MD, PhD, as Newest Board Member
13•11•23
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer
13•11•23
Portfolio News
Caristo Diagnostics
American Heart Association Presentation found that AI technology used by Caristo can predict fatal and not-fatal cardiac events
07•11•23
Portfolio News
Ultromics
CMS publishes final Clinical APC rule for Ultromics EchoGo® Heart Failure
01•11•23
Portfolio News
Sitryx
Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases
31•10•23
OSE News
Oxford Science Enterprises strengthens Health Tech team with appointments of two new Entrepreneurs in Residence
24•10•23
Portfolio News
Neu.Health Digital
Neu Health Announces Key Appointments to its Board of Directors
20•10•23
Portfolio News
Neu.Health Digital
Neu Health is Revolutionizing Neurology Care with $3.6 Million in Funding
20•10•23
Portfolio News
Brill Power
Brill Power brings sustainable battery technology to 18th century Victorian mansion in UK first
12•10•23
Portfolio News
PepGen
PepGen Inc. Announces FDA has Lifted the Clinical Hold on its Investigational New Drug Application
03•10•23
OSE News
The Oxford-Harrington Rare Disease Centre Launches
02•10•23
Portfolio News
Refeyn
Refeyn announces appointment of a new CEO
29•09•23
Portfolio News
Caristo Diagnostics
British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day
27•09•23
Portfolio News
Sitryx
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
26•09•23
Portfolio News
OMass Therapeutics
OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
20•09•23
Oxford ranked third most intensive science and innovation cluster in the world
20•09•23
Portfolio News
Navenio
Navenio Secures $6.3m to Boost Efficiency and Capacity for Patient Care Delivery Teams
18•09•23
Portfolio News
NavLive
NavLive launches with a mission to revolutionise building projects
14•09•23
Portfolio News
Alveogene
AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders
11•09•23
Portfolio News
Iota Sciences
iotaSciences presents first encouraging data for use of new isoPick™ Single-Cell Picker for mass spectrometric analysis of single cells
11•09•23
Portfolio News
Orbit Discovery
Orano Med and Orbit Discovery enter Collaboration to discover novel targeted radioligand therapies for cancer
06•09•23
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
06•09•23
Portfolio News
PepGen
PepGen Inc. Announces Clearance of CTA by Health Canada to Begin the FREEDOM-DM1 Phase 1 Study of PGN-EDODM1 in Patients with Myotonic Dystrophy Type 1
06•09•23
Portfolio News
Iota Sciences
iotaSciences and Quantum Design China Enter into Distribution Agreement
05•09•23
Portfolio News
Amber Therapeutics
Amber Tx acquires Bioinduction Limited
31•08•23
OSE News
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
09•08•23
Portfolio News
Evox Therapeutics
Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform
08•08•23
Portfolio News
PepGen
PepGen Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
04•08•23
Portfolio News
Evox Therapeutics
Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease
03•08•23
Portfolio News
Iota Sciences
iotaSciences Appoints Dr. Michael Lutz as New Chief Executive Officer
02•08•23
Portfolio News
Ultromics
New Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF Diagnosis
31•07•23
Portfolio News
Ultromics
Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View
12•07•23
Portfolio News
Prolific
Prolific announces £25m funding to improve AI systems with high quality, verifiable human insights
12•07•23
Portfolio News
Caristo Diagnostics
Caristo Diagnostics Piloting New Cardiac Disease Diagnostic Technology in UK NHS Hospitals
05•07•23
Portfolio News
Fluorok
FluoRok launches with £3 million of funding to revolutionise the way fluorochemicals are produced
22•06•23
Portfolio News
Caristo Diagnostics
Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease
21•06•23
Portfolio News
Barinthus Biotherapeutics
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
20•06•23
Portfolio News
Evox Therapeutics
Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property
12•06•23
Portfolio News
Beacon Therapeutics
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
09•06•23
Portfolio News
Theolytics
Theolytics presents data on THEO-260 and THEO-310 at ASCO and EHA
30•05•23
Portfolio News
Mixergy
EDP investment brings Mixergy to Portugal
30•05•23
Portfolio News
PQShield
PQShield partners with Tata Consultancy Services and eShard
24•05•23
Portfolio News
Quantum Motion Technologies
Sony Innovation Fund Joins Largest UK Quantum Investment in Second Close of Quantum Motion’s Funding Round
22•05•23
OSE News
Oxford University retains No. 1 spot for spinouts
21•05•23
Portfolio News
Orca Computing
ORCA Computing works with NVIDIA to implement hybrid quantum/classical algorithms
19•05•23
Portfolio News
Covatic
The investment enables the privacy-first ad tech company to improve and scale its audience segmentation solution, A-Type
19•05•23
Portfolio News
Natcap
natcap releases new guide to the nature reporting landscape
18•05•23
OSE News
PHTA and Oxford Science Enterprises join forces to support early stage startups
17•05•23
Portfolio News
Evox Therapeutics
Evox Therapeutics granted key US exosome purification patent
15•05•23
Portfolio News
OMass Therapeutics
OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension
02•05•23
Portfolio News
Oxford Flow
Oxford Flow gas regulators approach 4 years of continuous, maintenance free operation
26•04•23
Portfolio News
Ultromics
Ultromics granted FDA Breakthrough Device Designation
24•04•23
OSE News
OSE partners with top universities and investors for launch of USIT Guide
19•04•23
Portfolio News
OMass Therapeutics
OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress
17•04•23
Portfolio News
Barinthus Biotherapeutics
Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile in Women with HPV
17•04•23
Portfolio News
Caristo Diagnostics
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
12•04•23
Portfolio News
PQShield
PQShield collaborates with NCCoE to ease the real-world implementation of quantum-resistant cryptography
03•04•23
Portfolio News
Orbit Discovery
Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals
28•03•23
Portfolio News
Grey Wolf Therapeutics
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours
27•03•23
Portfolio News
Mixergy
Mixergy secures £9.2 million investment to expand their home energy and heat storage technology
20•03•23
Portfolio News
SpyBiotech
SpyBiotech Receives Grant from the Bill & Melinda Gates Foundation
13•03•23
Portfolio News
Oxford Flow
Oxford Flow launch a new gas regulator size calculator and liquid regulator size calculator
27•02•23
Portfolio News
Oxford Nanoimaging
ONI Appoints Paul Scagnetti as CEO to Implement Next Chapter of Growth
21•02•23
Portfolio News
Quantum Motion Technologies
Quantum Motion Raises £42 Million Investment Round
20•02•23
Portfolio News
Archangel Lightworks
Archangel Lightworks secures £4 million seed round to build next generation lasercom technology
14•02•23
Portfolio News
SpyBiotech
Spybiotech appoints industry veteran Eddie Gray as Chair of its Board of Directors
07•02•23
OSE News
Our 2022 Highlights
07•02•23
OSE News
Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner
06•02•23
Portfolio News
Iota Sciences
iotaSciences launches new isoPick™ single-cell picker to further expand handling solutions for efficient cell biology & gene therapy applications
02•02•23
Portfolio News
Orbit Discovery
Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics
01•02•23
Portfolio News
Scenic Biotech
Scenic Biotech enters cooperative research and development agreement with the National Institutes of Health for genetic modifier-based treatment approach for Niemann-Pick Type C Disease
31•01•23
Portfolio News
Barinthus Biotherapeutics
Vaccitech appoints industry veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
26•01•23
Portfolio News
Grey Wolf Therapeutics
Grey Wolf Therapeutics closes oversubscribed $49 million Series B financing to advance first-of-its-kind neoantigen creation approaches
26•01•23
Portfolio News
First Light Fusion
First Light Fusion to build demonstration facility at UKAEA’s Culham Campus
24•01•23
Portfolio News
Amber Therapeutics
Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence
20•01•23
Portfolio News
Scenic Biotech
Scenic Biotech strengthens drug discovery expertise in management team with the addition of Kristof Van Emelen
09•01•23
Portfolio News
Oxford Ionics
Oxford Ionics announces £30m series A funding
06•01•23
Portfolio News
Perspectum
Perspectum completes $36 million first close of series C funding led by Oppenheimer Holding
05•01•23
Portfolio News
Argonaut Therapeutics and Celleron Therapeutics announce completion of merger to form IngenOx Therapeutics
05•01•23
Portfolio News
Orbit Discovery
Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs
13•12•22
Portfolio News
First Light Fusion
First Light Fusion congratulates the National Ignition Facility on its maiden gain result
13•12•22
OSE News
OxfordVR to combine with BehaVR to confront the mental health crisis with the largest VR delivery platform for evidence-based digital therapeutics
12•12•22
Portfolio News
First Light Fusion
First Light welcomes news of possible 'Net Energy Gain' success at The National Ignition Facility
07•12•22
Portfolio News
PepGen
PepGen announces IND-enabling preclinical data supporting progression of PGN-EDODM1 into clinical studies
06•12•22
Portfolio News
Ultromics
Ultromics receives FDA clearance for its breakthrough device EchoGo Heart Failure
29•11•22
Portfolio News
Navenio
Bill Kloes joins Navenio as Chief Operating Officer to drive US expansion
28•11•22
Portfolio News
First Light Fusion
First Light Fusion targets 60 MW pilot plant to accelerate tritium production
21•11•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech to host KOL webinar on the SNAPvax™ platform for inducing tolerance to treat celiac and other autoimmune diseases
16•11•22
Portfolio News
Orca Computing
ORCA Computing hires Per Nyberg as Chief Commercial Officer
14•11•22
Portfolio News
PepGen
PepGen announces positive preclinical data for PGN-EDO53, PGN-EDO45 and PGN-EDO44, three novel duchenne muscular dystrophy candidates
10•11•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech reports third quarter 2022 financial results and recent corporate developments
10•11•22
Portfolio News
OMass Therapeutics
Publication in Nature Chemistry between Omass Therapeutics and co-founder Dame Carol Robinson demonstrates the benefits of native mass spectrometry in the interrogation of target ecosystems and drug discovery
10•11•22
Portfolio News
PepGen
PepGen reports third quarter 2022 financial results and recent corporate developments
07•11•22
Portfolio News
Genomics
Genomics announces successful world-first pilot using improved genomic risk assessment in cardiovascular disease prevention in the NHS
07•11•22
Portfolio News
Osler Diagnostics
Osler Diagnostics raises $85 million in Series C financing
03•11•22
Portfolio News
Util closes $6 million seed investment round led by Eldridge
01•11•22
Portfolio News
Evolito
Evolito appoints Chris Harris as Chief Executive Officer
25•10•22
Portfolio News
Quantum Motion Technologies
Quantum Motion industry milestone brings mass production of quantum chips closer
23•10•22
Portfolio News
Scenic Biotech
Scenic Biotech appoints Jens Würthner as Chief Medical Officer
19•10•22
OSE News
DJS Antibodies
DJS Antibodies to be acquired by AbbVie
19•10•22
Portfolio News
DJS Antibodies
AbbVie acquires DJS Antibodies, further strengthening immunology pipeline
18•10•22
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines
12•10•22
Portfolio News
PepGen
PepGen presents data from its Duchenne Muscular Dystrophy program at World Muscle Society Congress
12•10•22
Portfolio News
Oxford Flow
Oxford Flow and KOSO Kent Introl announce global partnership
11•10•22
OSE News
Oxford University named world's top university for the 7th consecutive year
09•10•22
Portfolio News
Genomics
Genomics announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
05•10•22
Portfolio News
Theolytics
Theolytics presents CAF-targeting therapy for stromal rich tumours and strengthens leadership team
28•09•22
Portfolio News
Ultromics
Ultromics joins FNIH partnership to transform heart failure detection
27•09•22
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits partners with Cyxtera to improve accessibility to quantum computers
27•09•22
Portfolio News
PepGen
PepGen reports positive data from Phase 1 trial of PGN-ED051 for the treatment of Duchenne Muscular Dystrophy
25•09•22
Portfolio News
First Light Fusion
Government Chief Scientific Adviser visits UK Atomic Energy Authority and First Light Fusion
25•09•22
Portfolio News
PepGen
PepGen appoints Habib Dable to Board of Directors
13•09•22
Portfolio News
Odqa
Odqa Renewable Energy Technologies emerges as frontrunner in the solar thermal industry with proprietary receiver technology
07•09•22
Portfolio News
Opsydia secures investment to drive growth in its innovative security solutions for the diamond sector
06•09•22
Portfolio News
Genomics
Genomics announces that Simon Dingemans has joined its board as the new chair
20•08•22
Portfolio News
Refeyn
Refeyn appoints Jean-Paul Mangeolle as new Non-Executive Director
11•08•22
Portfolio News
PepGen
PepGen reports second quarter 2022 financial results and recent corporate developments
08•08•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech reports second quarter 2022 financial results and recent corporate developments
03•08•22
Portfolio News
MiroBio
Gilead Sciences to acquire MiroBio
03•08•22
OSE News
MiroBio
MiroBio to be acquired by Gilead Sciences for approximately $405 million
21•07•22
Portfolio News
PepGen
PepGen appoints Caroline Godfrey, Ph.D. to the company's scientific advisory board
20•07•22
Portfolio News
First Light Fusion
First Light Fusion strikes long-term collaboration agreement with engineering leaders IDOM
19•07•22
Portfolio News
Brill Power
Brill powering its way to make batteries smarter with $10.5m Series A round
17•07•22
OSE News
Oxford Science Enterprises raises £250 million
14•07•22
Portfolio News
OMass Therapeutics
OMass Therapeutics appoints Dr Jon Roffey as Vice President, Head of Medicinal Chemistry
11•07•22
Portfolio News
SpyBiotech
SpyBiotech appoints seasoned biotech executive Mark Leuchtenberger as Chief Executive Officer
05•07•22
Portfolio News
Oxford Ionics
Oxford Ionics and Infineon join forces to develop leading trapped ion quantum processors
04•07•22
Portfolio News
Evolito
Evolito acquires Electroflight
04•07•22
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits raises £38 million Series A to accelerate R&D and expand into Asia-Pacific
04•07•22
Portfolio News
PQShield
PQShield algorithms to be standardised as the National Institute of Standards and Technology (NIST) announces the first international Post-Quantum Cryptography standards
28•06•22
Portfolio News
MiroBio
MiroBio raises $97 million Series B financing to develop checkpoint agonists for treatment of autoimmune diseases
21•06•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of anti-PD-1
15•06•22
Portfolio News
PepGen
PepGen reports first quarter 2022 financial results and recent corporate developments
13•06•22
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Dina Anderson as Vice President of Operations
09•06•22
Portfolio News
Orca Computing
Orca Computing provides UK MoD with first quantum computer
08•06•22
Portfolio News
Bibliu
EdTech leader BibliU raises $15 million in Series B funding
08•06•22
Portfolio News
Orca Computing
Orca Computing completes $15 million Series A funding round
05•06•22
Portfolio News
Barinthus Biotherapeutics
Arbutus and Vaccitech dose first patient in Phase 2a clinical trial combining therapies for the treatment of chronic hepatitis B virus
31•05•22
Portfolio News
Theolytics
Theolytics' £1m project with Innovate UK to develop a novel therapy for multiple myeloma patients
30•05•22
Portfolio News
MoA Technology
MoA Technology raises $44 million in Series B financing to progress novel herbicide pipeline
21•05•22
Portfolio News
Perspectum
FDA grants clearance to Perspectum's CoverScan - A new platform-based tool to assess multiple organs in one MRI scan
11•05•22
Portfolio News
Salience Labs
Salience Labs raises $11.5 million seed to develop ultra high-speed chips using photonics for AI applications
05•05•22
Portfolio News
Oxford Flow
Oxford Flow’s ES valve wins prestigious engineering award at (OTC) Offshore Technology Conference
04•05•22
Portfolio News
PepGen
PepGen announces pricing of initial public offering
28•04•22
Portfolio News
SpyBiotech
Studies using SpyBiotech’s vaccine technology shows potential against Covid-19 and other coronaviruses
27•04•22
Portfolio News
OMass Therapeutics
OMass Therapeutics raises $100 million in Series B financing to progress drug pipeline in immunology and rare diseases
20•04•22
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Phil Boyd as Chief Financial Officer
18•04•22
OSE News
Oxford Science Enterprises appoints Richard Laxer, former Chairman and CEO of GE Capital, as a Non-Executive Director
12•04•22
Portfolio News
Util announces the closing of a seed round
10•04•22
Portfolio News
Refeyn
Refeyn closes Series B funding round
06•04•22
Portfolio News
OxfordVR technology a world-first success in automating psychological therapy using virtual reality
06•04•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech announces notification of milestone and royalty revenue relating to sales of Vaxzevria
05•04•22
Portfolio News
OMass Therapeutics
Publication in Nature by OMass Founder, Professor Dame Carol Robinson, shows power of native mass spectrometry in drug discovery
05•04•22
Portfolio News
PepGen
PepGen announces first participant dosed in a Phase 1 clinical trial of PGN-EDO51 for the treatment of Duchenne Muscular Dystrophy
04•04•22
Portfolio News
First Light Fusion
First Light Fusion achieves world first fusion result, proving unique new target technology
04•04•22
Portfolio News
PepGen
PepGen appoints Michelle Mellion, M.D., as Senior Vice President, Head of Clinical Development
03•04•22
OSE News
New report highlights Oxford as the UK’s leading University for spinout creation with Oxford Science Enterprises named as most active fund focused solely on a single institution
30•03•22
OSE News
Oxford Science Enterprises strengthens investment teams with two new appointments
29•03•22
Portfolio News
PepGen
PepGen continues to build leadership team with additions of Senior Vice President, Clinical Operations and Vice President, Toxicology
29•03•22
Portfolio News
Scenic Biotech
Scenic Biotech and the Barth Syndrome Foundation announce partnership to explore genetic modifiers to find tailored treatment for complex rare disease
25•03•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech reports full-year 2021 financial results and recent corporate developments
22•03•22
Portfolio News
Bibliu
Higher education tech leader BibliU announces learning enablement platform
22•03•22
Portfolio News
Mixergy
Mixergy partners with UK’s largest online plumbing and heating merchant to offer full range of tanks nationwide
21•03•22
Portfolio News
Osler Diagnostics
Osler Diagnostics publishes update on its breakthrough product, the Osler Origin
21•03•22
Portfolio News
Osler Diagnostics
Osler Diagnostics appoints Chris Smith as Chairman of the Board and David Berry as a Non-Executive Director
16•03•22
Portfolio News
Mind Foundry
Mind Foundry win CogX Explainable AI Award for 2022
15•03•22
Portfolio News
PepGen
PepGen announces approval by Health Canada of CTA to begin first in human trials of PGN-EDO51 to treat Duchenne Muscular Dystrophy
14•03•22
OSE News
Oxford Science Enterprises enters agreement with Lothbury to develop state-of-the-art R&D facilities in Oxford City Centre
10•03•22
Portfolio News
Scenic Biotech
Scenic Biotech announces $31 million financing to progress pipeline of genetic modifiers in cancer and rare diseases
08•03•22
Portfolio News
MiroBio
MiroBio continues expansion of executive leadership team with key appointments to advance development of checkpoint agonist antibodies for autoimmune disease
07•03•22
Portfolio News
OMass Therapeutics
OMass Therapeutics establishes scientific advisory board of leading experts
07•03•22
Portfolio News
Orbit Discovery
Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies
04•03•22
Portfolio News
OMass Therapeutics
Omass Therapeutics OdyssION™ drug discovery platform makes progress in drugging the undruggable
01•03•22
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits becomes first european quantum company on Amazon Braket
15•02•22
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics appoints Nigel Clark as Chief Business Officer
15•02•22
Portfolio News
Ultromics
Ultromics: Wolverhampton NHS cardiologists to use new cloud technology to interpret echocardiograms
14•02•22
Portfolio News
First Light Fusion
First Light Fusion announces close of Series C fund raise
11•02•22
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics announces formation of advisory board
11•02•22
OSE News
Oxford Science Enterprises strengthens investment teams with two senior appointments
09•02•22
Portfolio News
Metaboards announces Executive Chairman appointment
09•02•22
Portfolio News
Refeyn
Refeyn announces the launch of its new TwoMP Auto mass photometer
07•02•22
Portfolio News
Opsydia introduces Surface ID System to complement existing sub-surface technology
07•02•22
Portfolio News
Quantum Motion Technologies
Quantum Motion opens new lab in London to build scalable quantum computer
27•01•22
Portfolio News
Perspectum
Perspectum announces first patient recruited for multi-year collaborative primary sclerosing cholangitis (PSC) pediatric study
26•01•22
Portfolio News
PQShield
PQShield raises $20 million in Series A funding to fuel global growth
25•01•22
OSE News
Oxford Science Enterprises enters 2022 with strengthened senior leadership team
20•01•22
Portfolio News
Brill Power
Brill Power announces Harwell Campus to provide testbed demonstrating energy storage innovations
20•01•22
Portfolio News
Oxford Nanoimaging
Oxford Nanoimaging closes $75 million Series B led by ARCH Venture Partners and Casdin Capital
18•01•22
Portfolio News
Barinthus Biotherapeutics
Vaccitech announces Cancer Research UK dose first patient in Phase I/IIa trial of lung cancer immunotherapy vaccine
16•12•21
Portfolio News
Navenio
Navenio secures $12.6 million investment to accelerate global growth in healthcare and beyond
16•12•21
OSE News
Oxford Science Enterprises Board update
15•12•21
Portfolio News
Ultromics
Ultromics breakthrough study shows AI is a capable of independently reading stress echocardiograms
15•12•21
Portfolio News
Alethiomics
Alethiomics launches to advance its multi-omics target discovery pipeline in blood cancer
14•12•21
Portfolio News
Circadian Therapeutics
Circadian Therapeutics announces the first subject recruited to Phase I study for CT-1500, marking move to a clinical stage company
13•12•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccines
07•12•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV
06•12•21
Portfolio News
Oxford Semantic Technologies
Dow Jones enhances product line with semantic innovation from Oxford Semantic Technologies
29•11•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits coming to Amazon Braket - bringing quantum to Europe
22•11•21
Portfolio News
Meltwater acquires AI spin-out from Oxford University’s Department of Computer Science to help build one of the largest knowledge graphs of public information
18•11•21
Portfolio News
Mixergy
Ecobubl: A new Mixergy stockist and training centre
16•11•21
Portfolio News
SpyBiotech
SpyBiotech announces the appointment of Simon Jones as VP, Finance and Operations and expansion of the scientific team
12•11•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech reports third quarter 2021 financial results and recent corporate developments
12•11•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech’s VTP-300 was well-tolerated and induced T cells against all targeted HBV antigens in both healthy volunteers and patients with chronic HBV infection in interim analyses
09•11•21
Portfolio News
Ultromics
Caption Health and Ultromics partner to put heart disease detection and management tools in more hands
08•11•21
Portfolio News
Caristo Diagnostics
Caristo Diagnostics announces CT coronary perivascular fat assessment can stratify cardiac risk associated with high-risk plaques
08•11•21
Portfolio News
Evox Therapeutics
Evox Therapeutics expands its exosome patent portfolio
08•11•21
Portfolio News
PepGen
PepGen bolsters R&D team with appointment of Jaya Goyal, Ph.D., as Executive Vice President of Research and Preclinical Development
05•11•21
Portfolio News
Navenio
Navenio and HERE Technologies to bring increased efficiency to indoor location & mapping with global partnership
05•11•21
Portfolio News
Nucleome Therapeutics
Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics
04•11•21
Portfolio News
OMass Therapeutics
OMass Therapeutics unveils rich drug discovery pipeline targeting intractable or inadequately drugged membrane and complex-bound proteins
04•11•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech announces publication of second Phase 1 clinical trial results of ChAdOx1 vaccine in development for the MERS coronavirus
03•11•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits collaborates with the National Quantum Computing Centre to boost UK quantum capability
01•11•21
Portfolio News
Bibliu
Wichita State University Campus of Applied Sciences and Technology adopts BibliU Universal Learning
01•11•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits pledges carbon neutrality by 2022
27•10•21
Portfolio News
PepGen
PepGen appoints Noel Donnelly as Chief Financial Officer
21•10•21
Portfolio News
Evox Therapeutics
Landmark paper highlights Evox Therapeutics’ cutting edge exosome engineering approach for enhanced surface display of biologics
06•10•21
Portfolio News
First Light Fusion
First Light Fusion represents UK fusion sector at the UK Government’s Global Investment Summit
05•10•21
Portfolio News
Brill Power
Brill Power launches the first in a new class of 'intelligent' battery management systems set to revolutionise battery performance
01•10•21
Portfolio News
Ultromics
Ultromics announces collaboration with Janssen to develop AI for patients with amyloidosis with cardiac involvement
30•09•21
Portfolio News
Opsydia technology advances to secure identity of melee diamonds
30•09•21
Portfolio News
PQShield
PQShield announces new hires to accelerate business growth
23•09•21
Portfolio News
Evolito
YASA spin-out Evolito to electrify aerospace market with ultra-high performance, low-weight electric motors
12•09•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits appoints Peter George as Chairperson of its Board
08•09•21
Portfolio News
PepGen
PepGen announces new additions to leadership team and Board of Directors
01•09•21
OSE News
Oxford University retains top spot in world rankings for 6th consecutive year
23•08•21
Portfolio News
Genomics
Genomics academic founder and CEO, Sir Peter Donnelly, awarded Royal Society Gabor medal
15•08•21
Portfolio News
Ultromics
Ultromics raises $33 million in Series B funding to help transform cardiac disease treatment
04•08•21
Portfolio News
PepGen
PepGen announces closing of $112.5 million crossover financing to advance transformative therapies for neuromuscular diseases
21•07•21
Portfolio News
Circadian Therapeutics
Circadian Therapeutics and Arquimea sign a collaboration agreement for the development of a molecule (AP-2) for the treatment of diseases affecting the nervous system
21•07•21
Portfolio News
YASA
Electric motor technology company YASA acquired by Mercedes-Benz
20•07•21
Portfolio News
Orbit Discovery
Orbit Discovery announces $7.6 million funding to accelerate growth in peptide discovery business
08•07•21
Portfolio News
Perspectum
Perspectum launches new clinical study to investigate integrated diagnostics to enable precision medicine for liver cancer patients
07•07•21
Portfolio News
Theolytics
Theolytics expands Series A financing and welcomes M Ventures as a new investor
06•07•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits delivers the UK’s first Quantum Computing as-a-Service
06•07•21
Portfolio News
Barinthus Biotherapeutics
Arbutus Biopharma and Vaccitech announce clinical trial collaboration for chronic hepatitis B virus infection
17•06•21
Portfolio News
Ultromics
Ultromics: EchoGo predicts cardiac-related COVID-19 mortality revealed in WASE study
16•06•21
Portfolio News
First Light Fusion
UK Science Minister Amanda Solloway MP to launch First Light Fusion’s maiden ‘Big Gun’ fusion campaign
14•06•21
Portfolio News
Brill Power
DNV verifies Brill Power’s new battery management system technology
07•06•21
Portfolio News
Oxford Nanoimaging
Oxford Nanoimaging among the +20 organisations brought together by the Cell and Gene Therapy Catapult to accelerate technology development in cell and gene therapy manufacturing
06•06•21
Portfolio News
PepGen
PepGen strengthens leadership team with SVP of Chemistry, Manufacturing & Controls and VP of Finance Appointments
24•05•21
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics announces appointment of Dr Jonathan Hepple as a Non-Executive Director to its Board
24•05•21
Portfolio News
Nucleome Therapeutics
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature
17•05•21
Portfolio News
Oxford Nanoimaging
Oxford Nanoimaging welcomes Dr Tyler Ralston as Chief Technology Officer
12•05•21
Portfolio News
First Light Fusion
First Light Fusion installs UK’s biggest two-stage hyper-velocity gas gun
03•05•21
Portfolio News
Perspectum
Perspectum partners in a new study in Singapore for the early detection of liver cancer using precision medicine
03•05•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech announces closing of $110.5 million initial public offering
28•04•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech announces pricing of initial public offering
26•04•21
Portfolio News
MoA Technology
MoA Technology raises a further £5 million in Series A financing bringing the total round to £12m
25•04•21
Portfolio News
Perspectum
Perspectum study shows measurable organ impairment in long COVID patients
19•04•21
Portfolio News
Ultromics
Ultromics CE mark's EchoGo Core
08•04•21
Portfolio News
Oxford Endovascular
Oxford Endovascular raises $10 million to develop its origami engineered medical device to prevent brain haemorrhage
30•03•21
Portfolio News
Quantum Motion Technologies
Quantum Motion computing breakthrough shows blueprint for scalable future
28•03•21
Portfolio News
Caristo Diagnostics
Caristo Diagnostics announces EU approval for AI technology which can predict heart attacks years in advance
28•03•21
Portfolio News
Perspectum
Perspectum research links high liver fat to increased risk of hospitalization in COVID-19 patients with obesity
22•03•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech appoints Joseph Scheeren, PharmD, to its Board of Directors
18•03•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech doses first patient in HPV001, a Phase 1/2 clinical trial of VTP-200 immunotherapeutic for high-risk persistent HPV infection
17•03•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech completes $168 million Series B financing to advance three clinical programs through Phase 2 results
08•03•21
Portfolio News
SpyBiotech
SpyBiotech announces the appointments of Dan Menichella as Non-Executive Director and Dr Norman Begg as Scientific Advisor
05•03•21
Portfolio News
MoA Technology
MoA Technology appoints Virginia Corless as Chief Executive Officer
02•03•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech appoints two independent board directors
01•03•21
Portfolio News
Genomics
Genomics completes oversubscribed $30m funding round
01•03•21
Portfolio News
Perspectum
Perspectum lands top spot in Alantra Pharma Fast 50 rankings
26•02•21
Portfolio News
PepGen
PepGen announces formation of scientific advisory board
25•02•21
Portfolio News
T-Cypher Bio
T-Cypher Bio separates from Orbit Discovery to build a pipeline of TCR therapeutics for solid tumours and other indications
18•02•21
Portfolio News
Evox Therapeutics
Evox Therapeutics completes £69.2 million Series C financing
17•02•21
Portfolio News
Brill Power
£2.5 million for intelligent battery technology start-up, Brill Power
16•02•21
Portfolio News
Mixergy
Mixergy tanks now included at CALA Homes development
10•02•21
Portfolio News
SpyBiotech
SpyBiotech raises $32.5 million in Series A funding and appoints Lutz B. Giebel as Chairman
04•02•21
Portfolio News
First Light Fusion
Professor Jerry Chittenden joins First Light Fusion’s Advisory Board
04•02•21
Portfolio News
PepGen
PepGen appoints James McArthur, Ph.D., as President and Chief Executive Officer
02•02•21
Portfolio News
Scenic Biotech
Scenic Biotech appoints Dr. Philippe Dro as Independent Chairman
01•02•21
Portfolio News
Barinthus Biotherapeutics
Vaccitech doses first patient in HBV002, a Phase 1b/2a clinical trial of VTP-300 immunotherapeutic candidate for chronic HBV patients
18•01•21
Portfolio News
Evox Therapeutics
John McHutchison joins the board of Evox Therapeutics
15•01•21
Portfolio News
Perspectum
Perspectum’s CoverScan MD approved by the UK’s MHRA – the world’s first integrated imaging service capable of mapping the impact of COVID-19 on the body
08•01•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits lab takes delivery of first Proteox worldwide
08•01•21
Portfolio News
Oxford Quantum Circuits
Oxford Quantum Circuits state-of-the-art quantum laboratory opens
07•01•21
Portfolio News
Oxford Flow
Ex-Centrica and BP boss Iain Conn joins the board of Oxford Flow
06•01•21
Portfolio News
Ultromics
Ultromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD
06•01•21
Portfolio News
Theolytics
Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies
05•01•21
Portfolio News
Perspectum
Perspectum issued CPT Codes for LiverMultiScan by the American Medical Association to help clinicians diagnose and treat liver disease
09•12•20
Portfolio News
HEXR
HEXR launches smartphone fitting app: Bespoke, 3D printed helmets now accessible to millions
09•12•20
Portfolio News
PepGen
PepGen raises $45M in Series A funding, led by RA Capital
01•12•20
Portfolio News
Counterfeit drugs and illegitimate vaccines, could be a thing of the past with new breakthrough testing technology from Proxisense and Oxford University
25•11•20
Portfolio News
Refeyn
Refeyn closes Series A funding round, led by Northpond Ventures
23•11•20
OSE News
Barinthus Biotherapeutics
Breakthrough for Oxford's covid vaccine, co-invented by Vaccitech
19•11•20
Portfolio News
Evox Therapeutics
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford
09•11•20
Portfolio News
Mind Foundry
Mind Foundry raises an additional $13.6 million in Series A funding
27•10•20
OSE News
Base Genomics
Oxford Science Enterprises announces the sale of Base Genomics to Exact Sciences
19•10•20
Portfolio News
Barinthus Biotherapeutics
Vaccitech expands management team with new hires, including CMO and CFO
12•10•20
OSE News
Oxford Science Enterprises appoints Alexis Dormandy as Chief Executive Officer
11•10•20
Portfolio News
First Light Fusion
First Light Fusion: Fusion energy can be the most cost competitive source of baseload power, at the same level as renewables
20•09•20
Portfolio News
Scenic Biotech
Scenic Biotech enters into genetic modifier collaboration with Genentech
29•04•20
Portfolio News
Barinthus Biotherapeutics
Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal